Fair Values of Assets and Liabilities | Fair Values of Assets and Liabilities Recurring Fair Value Measures The tables below present certain of our assets measured at fair value at March 31, 2022 and December 31, 2021, categorized by the level of input used in the valuation of each asset. As of March 31, 2022 Description Total Quoted Prices in Significant Significant Cash equivalents (1) $ 49,852 $ 49,852 $ — $ — Investments: Total equity investments (2) 11,895 6,102 5,793 — Total debt investments (3) 9,575 4,338 5,237 — Total investments 21,470 10,440 11,030 — Total $ 71,322 $ 60,292 $ 11,030 $ — As of December 31, 2021 Description Total Quoted Prices in Significant Significant Cash equivalents (1) $ 26,417 $ 26,417 $ — $ — Investments: Total equity investments (2) 13,033 6,980 6,053 — Total debt investments (3) 10,375 4,612 5,763 — Total investments 23,408 11,592 11,816 — Total $ 49,825 $ 38,009 $ 11,816 $ — _______________________________________ (1) Cash equivalents consist of short-term, highly liquid investments and money market funds held primarily for obligations arising from our self-insurance programs. Cash equivalents are reported in our condensed consolidated balance sheets as cash and cash equivalents and current and long-term restricted cash and cash equivalents. Cash equivalents include $23,611 and $23,546 of balances that were restricted at March 31, 2022 and December 31, 2021, respectively. In addition to the cash equivalents of $49,852 and $26,417 at March 31, 2022 and December 31, 2021, respectively, reflected above, there were cash balances of $61,813 and $64,116 and restricted cash balances of $2,513 and $2,406 at March 31, 2022 and December 31, 2021, respectively. (2) The fair value of our equity investments is readily determinable. During the three months ended March 31, 2022 and 2021, we received gross proceeds of $481 and $337, respectively, in connection with the sales of equity investments and recorded gross realized gains totaling $0 and $96, respectively, and gross realized losses totaling $42 and $0, respectively. (3) As of March 31, 2022, our debt investments, which are classified as available for sale, had a fair value of $9,575 with an amortized cost of $9,773; the difference between the fair value and amortized cost amounts resulted from net unrealized losses of $198, inclusive of unrealized gains of $51. As of December 31, 2021, our debt investments had a fair value of $10,375 with an amortized cost of $10,079; the difference between the fair value and amortized cost amounts resulted from net unrealized gains of $296, net of unrealized losses of $10. Debt investments include $6,386 and $6,907 of balances that were restricted as of March 31, 2022 and December 31, 2021, respectively. At March 31, 2022, 69 debt investments we held, with a fair value of $5,055, had been in a loss position for less than 12 months and one of the debt investments we held, with a fair value of $51, had been in a loss position for greater than 12 months. We do not believe these investments are impaired primarily because they have not been in a loss position for an extended period of time, the financial conditions of the issuers of these investments remain strong with solid fundamentals as of March 31, 2022, we do not intend to sell the investments and it is not more likely than not that we will be required to sell the investments before recovery, and other factors that support our conclusion that the loss is temporary. During the three months ended March 31, 2022 and 2021, we received gross proceeds of $204 and $0, respectively, in connection with the sales of debt investments and recorded gross realized losses of $3 and gross realized gains of $0 during the three months ended March 31, 2022. We record gains and losses on the sales of these investments using the specific identification method. The amortized cost basis and fair value of available for sale debt securities at March 31, 2022, by contractual maturity, are shown below. Amortized Cost Fair Value Due in one year or less $ 1,398 $ 1,407 Due after one year through five years 3,743 3,729 Due after five years through ten years 3,552 3,435 Due after ten years 1,080 1,004 Total $ 9,773 $ 9,575 Our financial assets (which include cash equivalents and investments) have been valued at the transaction price and subsequently valued, at the end of each reporting period, utilizing third-party pricing services or other market observable data. During the three months ended March 31, 2022, we did not change the type of inputs used to determine the fair value of any of our assets and liabilities that we measure at fair value. The carrying value of accounts receivable and accounts payable approximates fair value as of March 31, 2022 and December 31, 2021. The carrying value and fair value of our debt was $67,192 and $67,142, respectively, as of March 31, 2022 and $6,783 and $7,689, respectively, as of December 31, 2021. These are categorized in Level 3 of the fair value hierarchy. We estimate the fair value of our debt by using discounted cash flow analyses and currently prevailing market terms as of the measurement date. Non-Recurring Fair Value Measures We review the carrying value of our long-lived assets, including our right-of-use assets and property and equipment, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset or asset group may not be recoverable. For the three months ended March 31, 2022 and 2021 there were no non-recurring fair value adjustments related to long-lived assets. |